Advance Care Planning and Palliative Care Consultation in Kidney Transplantation
Marlena C Fisher,Xiaomeng Chen,Deidra C Crews,Lyndsay DeGroot,Nwamaka D Eneanya,Nidhi Ghildayal,Marshall Gold,Yi Liu,Justin J Sanders,Jennifer S Scherer,Dorry L Segev,Mara A McAdams-DeMarco,Marlena C. Fisher,Deidra C. Crews,Nwamaka D. Eneanya,Justin J. Sanders,Jennifer S. Scherer,Dorry L. Segev,Mara A. McAdams-DeMarco
DOI: https://doi.org/10.1053/j.ajkd.2023.07.018
IF: 11.072
2023-09-01
American Journal of Kidney Diseases
Abstract:RATIONALE & OBJECTIVE: <AbstractText Label="RATIONALE & OBJECTIVE" NlmCategory="OBJECTIVE">Due to the high risk of waitlist mortality and post-transplant complications, kidney transplant (KT) patients may benefit from advance care planning (ACP) and palliative care consultation (PCC). We quantified the prevalence and racial disparities in ACP and PCC among KT candidates and recipients.</AbstractText>STUDY DESIGN: <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Prospective cohort study SETTING & PARTICIPANTS: 2,575 adult KT candidates and 1,233 adult recipients (2008-2020).</AbstractText>EXPOSURE: <AbstractText Label="EXPOSURE" NlmCategory="METHODS">Race and ethnicity.</AbstractText>OUTCOMES: <AbstractText Label="OUTCOMES" NlmCategory="RESULTS">All reports of ACP and PCC were abstracted from chart review. ACP was defined as patient self-report of an advance directive, presence of an advance directive in the medical record, or a documented goals-of-care conversation with a provider. PCC was defined as an ordered referral, or a documented palliative care note in the medical record.</AbstractText>ANALYTICAL APPROACH: <AbstractText Label="ANALYTICAL APPROACH" NlmCategory="METHODS">Racial/ethnic disparities in ACP/PCC were estimated using adjusted logistic regression.</AbstractText>RESULTS: <AbstractText Label="RESULTS" NlmCategory="RESULTS">21.4% of candidates and 34.9% of recipients engaged in ACP. There were racial/ethnic disparities in ACP among candidates (White=24.4%, Black=19.1%, Hispanic=15%, Other race and ethnicity=21.1% p=0.008) and recipients (White=39.5%, Black=31.2%, Hispanic=26.3%, Other race and ethnicity=26.6% p=0.007). After adjustment, Black recipients had a 29% lower likelihood of engaging in ACP (odds ratio [OR]=0.71, 95% confidence interval [CI]:0.55-0.91) than White recipients. Among older (aged ≥65 years) recipients, those who were Black had a lower likelihood of engaging in ACP, but there was no racial disparity among younger recipients (p<sub>interaction</sub>=0.020). 4.2% of candidates and 5.1% of recipients engaged in PCC; there were no racial disparities in PCC among candidates (White=5.3%, Black=3.6%, Hispanic=2.5%, Other race and ethnicity=2.1%, p=0.13) or recipients (White=5.5%, Black=5.6%, Hispanic=0.0%, Other race and ethnicity=1.3% p=0.21).</AbstractText>LIMITATIONS: <AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Generalizability may be limited to academic transplant centers.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ACP is not common among KT patients and minoritized transplant patients are least likely to engage in ACP; PCC is less common. Future efforts should aim to integrate ACP and PCC into the KT process.</AbstractText>
urology & nephrology